Skip to main content

Table 3 Clinical and pathological characteristics of the CHEK2 c.1100delC carriers

From: CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Age range at diagnosis T N M Histology ER PR Grade Her2 Family history of breast cancer Family history of prostate cancer Family history of ovarian cancer BRCA1/2 mutation
65–70 1 1 0 Ductal Positive Positive 3 n.a. n.a. n.a. n.a. Negative
45–50 1 0 0 Ductal Positive Negative 2 n.a. Negative Negative Negative Negative
40–45 1 1 0 Ductal Positive Negative 3 Negative Positive n.a. n.a. Negative
75–80 1 0 0 Ductal Positive Positive 2 Positive Negative n.a. n.a. Negative